Back to search

National and Kapodistrian University of Athens

Το σύστημα της πρωτεΐνης C και η γενετική της θρομβοφιλίας

Abstract

dc:description

The protein C pathway plays an important role in the regulating of formation of fibrin. The normal blood flow depends on the precise binding on the surface of endothelial cells of thrombin (T), thrombomodulin (TM), protein C (PC) and (endothelial receptor protein C) EPCR. Thrombomodulin is an important cofactor in the protein C pathway and an endothelial receptor for thrombin which plays an important role in the regulation of blood clotting, reducing the activity of thrombin and enhancing the activation of protein C. Scanning of thrombomodulin gene in patients who had one or more thrombotic episodes in young age has revealed several mutations and/or polymorphisms , some of which are associated with venous thrombosis (VTE). Endothelial receptor protein C is a transmembrane protein, which is expressed in the endothelium of large vessels, binds protein C (PC) and enhances its activation. The involvment of EPCR in hemostasis suggests a possible role in the pathogenesis of VTE. Genetic abnormalities affecting the gene of thrombomodulin and th endothelial protein C receptor may be associated with disturbances in the protein C pathway and therefore associated with an increased risk for thrombotic events.The purpose of this study was to investigate the appearance of 127G/A and 1456G/T mutations in the TM gene and the appearance of the two most common polymorphisms in the EPCR gene, 4600A/G in exon 4 that predicts a substitution of Ser219 by Gly in the transmembrane region of EPCR and 4678G/C in the 3’-UT region, in young patients with thrombosis as well as their impact on the risk of VTE, on the age of the first thrombotic episode and recurrence. We recruited 84 patients aged 22-83, as well as a control group of 100 healthy individuals matched for age and sex. All individuals were Caucasians and completed a detailed questionnaire including data of personal and family history of thrombosis, malignancy and drug intake. The study was approved by the local ethics committee and all the subjects gave their informed consent. Real-time polymerase chain reaction (RT-PCR) was used for the identification of 127G/A and 1456G/T mutations in the TM gene and the 4600A/G and 4678G/C polymorphisms in EPCR gene (LightCycler 2.0 Instrument, Roche Diagnostics GmbH). Patients were also studied for hereditary thrombophilia [FV Leiden and FII G20210A, deficiency of natural inhibitors of coagulation (PrC, PrS, and AT)].The FV Leiden and FII G20210A mutations were assessed by PCR and reverse hybridization that concurrently detects these two mutations (FV-PTH SripAssay, VIENNALAB, AUSTRIA). Automated hemostasis analyzer BCS System (Siemens GmbH) was used to determine the activity of natural inhibitors of coagulation.In our study, it appears that 127G/A and 1456G/T mutations is not a common risk factor of VTE in the Greek population. As far as, EPCR polymorphisms is regarded, frequency of the EPCR 4600A/G and 4678G/C genotype was comparable in patients and controls (p=0.7 and p=0.5 respectively). However, in a subset analysis we observed that the EPCR 4600A/G genotype was more prevalent (69.3%) in patients who developed VTE earlier (<35) compared to older age groups. Moreover, the EPCR 4678C/C genotype confers a protective advantage for VTE in terms of age of first thrombotic manifestation.The insights gained from studies that evaluate the involvement of EPCR polymorphisms in the risk of VTE may not only elucidate underlying pathophysiological mechanisms but also their clinical significance and the interplay between these polymorphisms and other congenital and/or epigenetic risk factors. Further studies including larger number of patients as well as detection of EPCR levels are required in order to clarify the implication, if any, of these polymorphisms in the pathogenesis of VTE.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Anastasiou, Georgia
  • Αναστασίου, Γεωργία

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40688

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Anastasiou, Georgia; Αναστασίου, Γεωργία. Το σύστημα της πρωτεΐνης C και η γενετική της θρομβοφιλίας. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/40688